NO20002343L - Procedure for potentiating intravenous estramustine phosphate - Google Patents

Procedure for potentiating intravenous estramustine phosphate

Info

Publication number: NO20002343L
Authority: NO; Norway
Prior art keywords: potentiating; procedure; estramustine phosphate; intravenous estramustine; intravenous
Prior art date: 1998-03-27

Application number

NO20002343A

Other languages

Norwegian (no)

Other versions

NO20002343D0 (en

Inventor

Michael S Kopreski

Beryl Asp

Bo Fredholm

Per-Olav Gunnarsson

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-27

Filing date

2000-05-04

Publication date

2000-05-04

2000-05-04 Application filed by Upjohn Co filed Critical Upjohn Co

2000-05-04 Publication of NO20002343D0 publication Critical patent/NO20002343D0/en

2000-05-04 Publication of NO20002343L publication Critical patent/NO20002343L/en

Links

229960004750 estramustine phosphate Drugs 0.000 title 1
ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title 1
238000001990 intravenous administration Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
230000003389 potentiating effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20002343A 1998-03-27 2000-05-04 Procedure for potentiating intravenous estramustine phosphate NO20002343L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7954298P	1998-03-27	1998-03-27
PCT/US1999/004275 WO1999049869A1 (en)	1998-03-27	1999-03-26	Methods to potentiate intravenous estramustine phosphate

Publications (2)

Publication Number	Publication Date
NO20002343D0 NO20002343D0 (en)	2000-05-04
NO20002343L true NO20002343L (en)	2000-05-04

Family

ID=22151209

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002343A NO20002343L (en)	1998-03-27	2000-05-04	Procedure for potentiating intravenous estramustine phosphate

Country Status (16)

Country	Link
EP (1)	EP1003521A4 (en)
JP (1)	JP2001508810A (en)
KR (1)	KR20010021656A (en)
CN (2)	CN1273530A (en)
AU (1)	AU750010B2 (en)
BR (1)	BR9906425A (en)
CA (1)	CA2295049A1 (en)
EA (1)	EA004647B1 (en)
HU (1)	HUP0200547A3 (en)
ID (1)	ID24504A (en)
IL (1)	IL133612A0 (en)
NO (1)	NO20002343L (en)
NZ (1)	NZ501987A (en)
PL (1)	PL342969A1 (en)
WO (1)	WO1999049869A1 (en)
ZA (1)	ZA997821B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003201D0 (en) *	2000-02-11	2000-04-05	Pharmacia & Upjohn Spa	Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) *	2000-07-25	2002-08-20	Pharmacia & Upjohn Company	Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (en) *	2011-05-04	2013-01-10	Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России)	Method of treating colonic liver metastases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS617292A (en) *	1984-06-20	1986-01-13	Japan Atom Energy Res Inst	Method for producing estracyt compound bonded with carcinostatic agent
US5077056A (en) *	1984-08-08	1991-12-31	The Liposome Company, Inc.	Encapsulation of antineoplastic agents in liposomes
MX9203808A (en) *	1987-03-05	1992-07-01	Liposome Co Inc	HIGH DRUG CONTENT FORMULATIONS: LIPID, FROM LIPOSOMIC-ANTINEOPLASTIC AGENTS.
ATE194767T1 (en) *	1992-03-23	2000-08-15	Univ Georgetown	TAXOL ENCAPSULATED IN LIPOSOMES AND METHOD OF USE
FR2697752B1 (en) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Antitumor compositions containing taxane derivatives.

1999
- 1999-03-26 ID IDW20000105A patent/ID24504A/en unknown
- 1999-03-26 CN CN99800823A patent/CN1273530A/en active Pending
- 1999-03-26 CN CNA2004100867183A patent/CN1636598A/en active Pending
- 1999-03-26 NZ NZ501987A patent/NZ501987A/en unknown
- 1999-03-26 EP EP99914884A patent/EP1003521A4/en not_active Withdrawn
- 1999-03-26 PL PL99342969A patent/PL342969A1/en unknown
- 1999-03-26 WO PCT/US1999/004275 patent/WO1999049869A1/en not_active Ceased
- 1999-03-26 KR KR1020007000214A patent/KR20010021656A/en not_active Ceased
- 1999-03-26 CA CA002295049A patent/CA2295049A1/en not_active Abandoned
- 1999-03-26 HU HU0200547A patent/HUP0200547A3/en unknown
- 1999-03-26 IL IL13361299A patent/IL133612A0/en not_active IP Right Cessation
- 1999-03-26 EA EA199901081A patent/EA004647B1/en not_active IP Right Cessation
- 1999-03-26 BR BR9906425-1A patent/BR9906425A/en not_active IP Right Cessation
- 1999-03-26 JP JP54936999A patent/JP2001508810A/en not_active Ceased
- 1999-03-26 AU AU33533/99A patent/AU750010B2/en not_active Ceased
- 1999-12-22 ZA ZA9907821A patent/ZA997821B/en unknown
2000
- 2000-05-04 NO NO20002343A patent/NO20002343L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9906425A (en)	2000-07-11
EA199901081A1 (en)	2000-12-25
ZA997821B (en)	2000-08-01
WO1999049869A1 (en)	1999-10-07
EA004647B1 (en)	2004-06-24
CN1636598A (en)	2005-07-13
HUP0200547A3 (en)	2003-07-28
NO20002343D0 (en)	2000-05-04
AU3353399A (en)	1999-10-18
KR20010021656A (en)	2001-03-15
HUP0200547A2 (en)	2002-07-29
JP2001508810A (en)	2001-07-03
NZ501987A (en)	2002-10-25
CA2295049A1 (en)	1999-10-07
EP1003521A1 (en)	2000-05-31
ID24504A (en)	2000-07-20
PL342969A1 (en)	2001-07-16
IL133612A0 (en)	2001-04-30
AU750010B2 (en)	2002-07-11
EP1003521A4 (en)	2003-07-23
CN1273530A (en)	2000-11-15

Legal Events

Date	Code	Title	Description
2006-10-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO991436D0 (en)	1999-03-24	The tieback connector
DE69933078D1 (en)	2006-10-19	Stent Aneurismic Treatment System
TR199800436A3 (en)	1998-10-21	The use of primidine derivatives for cancer prevention.
NO974554L (en)	1998-07-15	Procedure for the treatment of an underground formation
IS5949A (en)	2001-05-22	Adds useful bicyclic derivatives that help prevent cancer
BR9904281B1 (en)	2013-11-19	MEDICATION DISTRIBUTION ASSEMBLY
NO20010046L (en)	2001-03-02	Dolastatin-15 derivatives
EP1109490A4 (en)	2005-03-02	MEDICAL IMPLANT SYSTEM
DE59903617D1 (en)	2003-01-16	patient connector
DE69933079D1 (en)	2006-10-19	catheter
DE69921764D1 (en)	2004-12-16	CATHETER
NO995251D0 (en)	1999-10-27	Procedure for administering halotherapy
DE69915677D1 (en)	2004-04-22	FORM SYSTEM
NO974972L (en)	1998-05-04	Procedure for preventing breast cancer
FI974493A0 (en)	1997-12-11	Arrangement of the hydraulic system
FR2776660B1 (en)	2000-05-12	DIAZEPINO-INDOLES OF PHOSPHODIESTERASES IV
DE50014156D1 (en)	2007-04-26	locking connection
FR2761589B1 (en)	1999-09-24	CATHETER, ESPECIALLY FOR NEUROSURGERY
DE69918354D1 (en)	2004-08-05	Priority agent system
ATE276234T1 (en)	2004-10-15	UREA DERIVATIVES FOR PAIN FIGHTING
TR199800403A3 (en)	1998-09-21	Method for the preparation of a-Bromo-lactam derivatives.
NO20002343D0 (en)	2000-05-04	Procedure for potentiating intravenous estramustine phosphate
PT1051172E (en)	2005-03-31	METHOD FOR TREATMENT OF THE DPCO
AUPP893399A0 (en)	1999-03-25	Site certificate system
NO20005148L (en)	2000-11-09	Process for preparing 4-substituted-1H-indole-3-glyoxamides